A case of erectile dysfunction and risk factors for coronary artery disease.
Authors:
Journal: International journal of impotence research
Publication Type: Journal Article
Date: 2005
DOI: 10.1038/sj.ijir.3901423
ID: 16391547
Abstract
The hypothetical case of a man with erectile dysfunction and multiple cardiovascular risk factors is presented to illustrate the use of the second Princeton Consensus Conference Guidelines. Methods to optimize efficacy of the phosphodiesterase inhibitors are described. The overall cardiovascular safety of the phosphodiesterase inhibitors and their interaction with organic nitrates and alpha blockers are discussed.
Chemical List
- Angiotensin-Converting Enzyme Inhibitors|||Enzyme Inhibitors|||Piperazines|||Purines|||Sulfones|||Sildenafil Citrate|||3',5'-Cyclic-GMP Phosphodiesterases